Delivery Order SPE2DB22D1052-SPE2DB25FU9VU
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine syringes (0.5mL) on August 11, 2025, with a ceiling value of $22,083.83. This firm fixed-price contract, with an ultimate completion date of August 12, 2025, represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with the DLA. The contract is unclassified as a set-aside and will be performed at the vendor's corporate office location in...
- The Defense Logistics Agency awarded a $75,338.45 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine in 0.5mL syringe format, with an ultimate completion date of August 18, 2025. This non-set-aside, competitively awarded contract represents a single delivery order fulfillment under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The vaccine will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $2,694.75 delivery order to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine syringes (0.5ML) on July 24, 2025, with an ultimate completion date of July 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine in syringe form (0.5mL) with a ceiling value of $1,064.40. This competitively awarded, firm fixed-price delivery order was issued on July 23, 2025, with an ultimate completion date of July 24, 2025. The contract utilizes no set-aside designation and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a $15,835.86 delivery order to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine in 0.5mL syringe format, with a completion date of July 23, 2025. This non-competitive delivery order represents a firm fixed price contract issued under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026. The vaccine will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,330.50 to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine in 0.5ML syringes. This competitively awarded, firm fixed-price delivery order was issued on August 14, 2025, with an ultimate completion date of August 15, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine syringes (0.5 mL) valued at $2,636.60 on August 1, 2025, with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The award is issued as a child contract under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine syringes (0.5mL) valued at $2,661.00 on July 24, 2025, with completion required by July 25, 2025. This is a firm fixed-price contract with no set-aside designation, and the product will be supplied from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $59,596.40 delivery order to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine in 0.5ML syringes. Executed on August 18, 2025, with an ultimate completion date of August 19, 2025, this firm fixed-price contract represents a competitively awarded non-set-aside delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award is sourced from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $1,064.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine syringes (0.5ML) on August 11, 2025, with completion targeted for August 12, 2025. This non-set-aside delivery order represents a small-value transaction under AmerisourceBergen's broader pharmaceutical supply arrangement with DLA. The product will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order...
- SPE2DB22D1052Indefinite Delivery Contract
- SPE2DB22D1052-SPE2DB25FU9VUDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 0.5ML Boostrix TDAP vaccine syringes with a contract value of $1,330.50 on August 14, 2025, with completion scheduled for August 15, 2025. This firm fixed price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The vaccine will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's comprehensive $999,999,999.00 Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which runs through December 2026 and serves as a global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, provides a broad range of pharmaceutical products and medical supplies to defense and veteran healthcare systems. The company has demonstrated capability to fulfill federal medical procurement requirements through multiple competitively awarded contracts involving various delivery orders with firm fixed pricing across diverse therapeutic domains and medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 8/14/25 |